Insider trades
Charles Elliott Sigal, Director of Vir Biotechnology VIR, has filed 4 purchases and 0 sales on the open market. The latest trade was on 05/27.
Charles Elliott Sigal
Director
- Company
- Vir Biotechnology VIR
- First filing
- 23/01/05
- Trades
- 21 trades
- Buys / sales
- 4 / 0
- 12-month net buying
- No record
- Last trade
- 05/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 23/03/01 | 23/03/02 | 2,500 sh | $22.73 | $56,825 | +33.3% | |
| Open-market buy | 23/01/05 | 23/01/09 | 2,500 sh | $24.96 | $62,400 | +50.0% | |
VIR | Open-market buy | 23/01/03–23/01/04 | 23/01/05 | 5,000 sh2 trades | $25.43avg. | $127,125 | No record |